While Panx1 was found to act as liver tumor promotor, Panx2 rather performs tumor-suppressive actions in human HCC (Shi et al., 2019[55]; Xie et al., 2015[63]). This evidence concerns the gene PANX2 and hepatocellular carcinoma.